athenahealth (ATHN) Remains Neutral-Rated at Goldman Sachs; Analyst Sees Limited Upside
Tweet Send to a Friend
Goldman Sachs maintained a Neutral rating on athenahealth (NASDAQ: ATHN) and raised its price target of $154.00 (from $135.00). Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
